Present results illustrate that ALKBH5 is a key m6A demethylase involved in regulating angiogenesis and post‐ischemic insult, thus providing experimental data for the potential therapeutic role of targeting ALKBH5 in the management of ischemic diseases via promoting post‐ischemic angiogenesis. Here, ALKBH5 is linked to ischemic disease.